Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 +0.53%68 FCF Yield % is 6.14 as of Jul. 15, 2026, which is 19% below its 10-year median of 7.59. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 570 Conglomerates companies, Medical Ikkou Group Co ranks better than 63.33% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medical Ikkou Group Co FCF Yield % Related Terms
Medical Ikkou Group Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co FCF Yield % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a FCF Yield % of 6.14 as of Jul. 15, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medical Ikkou Group Co and its competitors. This is 19% below median its historical median of 7.59. According to the industry distribution chart, Medical Ikkou Group Co ranks #209 out of 570 companies in the Conglomerates industry, placing it in the top 36.7%.
Is Medical Ikkou Group Co's FCF Yield % too high?
Medical Ikkou Group Co's current FCF Yield % of 6.14 is 19% below median its 10-year median of 7.59. The Conglomerates industry median FCF Yield % is 2.49. Medical Ikkou Group Co's value of 6.14 is 147.1% above this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #209 out of 570 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's FCF Yield % compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #209 out of 570 companies for FCF Yield %. This puts Medical Ikkou Group Co in the upper half of its industry. The industry median FCF Yield % is 2.49. Medical Ikkou Group Co's value of 6.14 is 147.1% above this benchmark. While the company's 10-year median is 7.59 vs. the industry median of 2.49, Medical Ikkou Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Conglomerates company?
The median FCF Yield % among Conglomerates companies is 2.49, based on 570 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current FCF Yield % of 6.14 is 147.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median FCF Yield % is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current FCF Yield % is 6.14, which is 19% below median its own 10-year median of 7.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current FCF Yield % is 6.14, which is 19% below median its 10-year median of 7.59 and 147.1% above the Conglomerates industry median of 2.49. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current FCF Yield % is 6.14 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
FCF Yield %: 6.14 (19% below median its 10-year median of 7.59)
GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
Industry Position: 147.1% above the Conglomerates median (#209 of 570)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score
Get the complete analysis for TSE:3353
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
